I mean no offense, but in the biotech space, it’s not just about current revenue or market cap. The real value is in the potential of those ideas, patents, and trial advancements. Dismissing the potential breakthroughs based solely on these numbers misses the bigger picture. It’s about future value, not just the present.
- Forums
- ASX - By Stock
- General discussion
I mean no offense, but in the biotech space, it’s not just about...
-
-
- There are more pages in this discussion • 268 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)